MS
IMMU

Maven Securities’s Immunomedics Inc IMMU Stock Holding History

Maven Securities’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-385,810
Closed -$32.8M – 965
2020
Q3 		$32.8M Buy
385,810
+160,610
+71% +$8.12M 2.71% 3
2020
Q2 		$7.98M Buy
+225,200
New +$6.58M 0.55% 30
2020
Q1 		– Sell
-772,460
Closed -$16.4M – 474
2019
Q4 		$16.4M Buy
+772,460
New +$13.6M 1.49% 12

Maven Securities's IMMU Position: Q4 2020 in Review

Maven Securities sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 385,810 shares — an estimated $32.8M sold.

Maven Securities first reported a position in IMMU in Q4 2019 and held it in 3 quarters. The position peaked at $32.8M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Maven Securities reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Maven Securities sold 385,810 Immunomedics Inc shares in Q4 2020, an estimated $32.8M.
  • Maven Securities first reported a position in Immunomedics Inc in Q4 2019 and held it in 3 quarters.
  • Maven Securities's Immunomedics Inc position peaked at $32.8M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Maven Securities's 13F filing for Q4 2020, filed 12 Feb 2021.